Gilead to test once-a-year HIV prevention shot
Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.
Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.
Healthcare giant Optum has restricted access to an internal AI chatbot used by employees after a security researcher found it was publicly accessible online, and…
This review focuses on DRESS, a serious drug-induced T-cell–mediated condition with marked cutaneous and systemic effects.
Artificial intelligence (AI) is enabling us to delve deeply into the information inherent in a mammogram and identify novel features associated with high risk of…
Resident physicians considering fellowship training should weigh how the subspecialty training fits into their life, financial and career goals.
Of the 78 top journals with guidance on the use of AI for peer review, 59% prohibit its use
Vaccines today are more efficient and contain far fewer stimulants to the immune system than some used decades ago.
Cell Reports and Cell Reports Physical Science joint special issue on mechanobiology.
Concerns about overdiagnosis of clinically insignificant prostate cancer through prostate specific antigen (PSA) screening motivated the 2018 American Academy of Family Physicians’ (AAFP) recommendation against…
Bill Hanage, associate professor of epidemiology at Harvard Chan School, discusses the potential pandemic risk posed by bird flu, currently circulating among cows.
The grave tells the story of an ancient warrior lost to time.